This article describes the knowledge-based system TheMPO (Therapy Management in Pediatric Oncology), which supports protocol-directed therapy planning and conguration in pediatric oncology. TheMPO provides a semantic network controlled by graph-grammars to cover the dierent types of knowledge relevant in the domain, and oers a suite of acquisition tools for knowledge base authoring. Medical problem solvers, operating on the oncological network, reason about adequate therapeutic and diagnostic time-tables for a patient. Furthermore, a corresponding patient record, also based on semantic networks and graph-grammars, has been implemented to represent the course of therapy of an oncological patient.
Introduction
The treatment o f c hildhood cancer is characterized by the application of standardized protocols containing diagnostic criteria, detailed instructions about chemo-and radiotherapy, and recommendations concerning the management of toxicity (e.g., [1] ). Due to these protocols, the prognosis of malignant c hildhood diseases has improved signicantly during the last two decades [2, 3] . However, this has gone hand in hand with an increasing complexity of treatment, and has led to new challenges and burdens for the medical sta, especially with regard to medical decision making and documentation. As a former program, restricted to the subtask of chemotherapy calculation in this domain (Catipo [4] ), has shown encouraging results in the clinical routine, it has been assumed that a larger knowledge-based system, providing a formal representation of the protocols as its core and therefore being able to support protocol-directed therapy and documentation, could be helpful for the medical sta involved in therapy. Therefore, the Department for Medical Statistics and Documentation of the University Hospital Mainz, Germany, has developed the knowledge-based system TheMPO 1 (Therapy Management in Pediatric Oncology), providing a) graphical tools for the acquisition of protocol knowledge, and b) problem-solving modules which determine an appropriate (sub)protocol for a given patient, and which congure and modify this protocol according to the patient's initial condition and his individual response during long-term treatment.
First of all, in the remaining part of this section, the structure of pediatric cancer therapy is analyzed. In section 2, three acquisition tools are introduced, which enable the physician to specify protocol knowledge, including a) timetables for chemo-and radiotherapy, b) therapy branches and branching points, and c) rule knowledge for therapy modication. The internal representation approach, which is based on semantic networks realized through attributed, directed and labeled graphs and graph-grammars, is described in section 3. Section 4 outlines the medical problem solving process which uses the protocol knowledge and the patient's data to suggest patient-adapted therapy timetables. The corresponding time-and context-oriented patient database, which is based on attributed graphs and graph-grammars too, is described in section 5. After having addressed implementation details in section 6, an overview concerning related work is given in section 7. Strengths and weaknesses of the current approach together with future research topics in the context of the TheMPO-project are discussed in section 8. As an initial remark, it has to be stated, that -for better presentation -some of the domain examples originating from protocols have been slightly simplied or modied (especially in section 2 and 4), to clarify the knowledge representation and processing done by the system. Therefore, only the original protocols should be used as knowledge source for the domain of pediatric oncology.
Protocol Structure in Pediatric Oncology
In pediatric oncology, protocols typically cover time periods from 6 months up t o 2 y ears, including initial diagnostics and assignment to dierent risk groups and therapy branches, intensive inpatient c hemo-and radiotherapy phases for tumor remission, consolidation therapy, and outpatient long-term therapy to avoid tumor recurrence. To analyze whether a new drug or drug combination is able to improve the prognosis, protocols often randomize patients of a particular risk group and assign them to dierent, competitive therapy branches. A typical chemotherapy m a y last from 4 days (chemotherapy N1 of the neuroblastoma protocol) up to 9 weeks (chemotherapy I of the acute lymphoblastic leukemia protocol ALL-BFM95), and may consist of 3 cytostatic drugs (N1) up to 10 drugs (HR-2 of ALL-BFM95). Depending on the initial prognosis, intensive c hemotherapy units may be administered up to 4 or 8 times sequentially, alternating with phases of recovering. Figure 1 illustrates the structure o f a t ypical protocol, and gure 2 describes the internal structure of a chemotherapy.
Furthermore, a knowledge-based system in this domain has to deal with the following types of temporal constraints and relationships: { Exact quantitative relations: Folin acid rescue should begiven exactly 42, 48 and 54 hours after the Methotrexate-infusion has started. { Inexact quantitative relations: Chemotherapy of type III(of brain tumor protocol) should start not earlier than 2 weeks after the start of the preceding chemotherapy of type II,but not later than 3 weeks. { Qualitative relations: Electrocardiography and echocardiography should be done before the rst and third administration of Adriamycin. In addition to this time-table knowledge valid for a patient collective, protocols also contain rule knowledge supplementing or overwriting the standard timetables, such as:
IF initial CNS-inltration has been observed THEN give Mtx intrathecal additionally at day 18 and 27 (and not only at day 1, 12, 33, 45, 59 ).
In summary, a knowledge-based system in the domain of pediatric oncology has to be able to represent time-tables of chemo-and radiotherapy, longterm sequences and stratications of therapy phases, additional rule knowl-
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Pred-GR + Leucocytes < 20000 + 1 <= Age < 6 + Non -T edge for patient-adapted therapy modication, and temporal constraints concerning the duration of therapy-intensive and therapy-free intervals. As especially modern chemotherapy is based not only on the drugs themselves and their dosages, but also on the complex and sophisticated temporal interaction structure of these drugs, special attention has to be paid to the adequate representation and processing of temporal knowledge.
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Knowledge Acquisition
To dene the structure of oncological protocols, TheMPO provides three graphical acquisition tools hiding the internal representation language from the physician. The rst tool, called TherapyEditor, enables the physician to dene cytostatic infusions and supportive medications, and to group these therapy elements together to dierent types of chemotherapy. Furthermore, phases of radiotherapy can be specied with the TherapyEditor as well.
With the second tool, called ProtocolEditor, the physician denes sequences of chemotherapy and radiotherapy phases which have been specied with the TherapyEditor. This includes the denition of constraints concerning the intervals between the successive phases, and the specication of stratication (branching) points. The third tool, the RuleEditor, which can beinvoked from both of the above tools, enables the physician to dene rule knowledge needed for instance to specify modication or discontinuation criteria valid for a particular chemotherapy, or to dene branching criteria for stratication points. All tools internally operate on the same semantic network, each tool having write access to a well-dened subnet. The following three sections briey illustrate the functionality of these acquisition tools. The structure of the underlying semantic network is described in section 3.
TherapyEditor
This tool is used to specify the basic components of a protocol, including cytostatic medications and types of chemotherapy. Figure 3 illustrates the specication of the internal temporal structure of the chemotherapy N1 within the neuroblastoma protocol. With the window shown in this gure, the physician has specied that the duration of this chemotherapy should beexactly 4 days; the infusions DDP (=Cisplatin) and VP16 (=Etoposide) are given every day. VDS (=Vin-desine) i s g i v en only at the rst day. The integer`1' in the`Pre-Administration'-eld of the VDS-column indicates that this drug should be given exactly one hour before the actual beginning of the chemotherapy, as this drug is stopping the cell division at a stage sensitive for the other cytostatic drugs. The entrỳ 100%' species that each drug is given with 100 percent of the daily dosage at every day of the administration (with exception of day 1 of the DDPapplication, where only 50 percent of the daily dosage are given to accustom the child to this drug). At the upper right, an icon has been assigned to this chemotherapy; this icon will be used as an identifying symbolby the ProtocolEditor. Detailed information about the involved drugs (such as the daily dosage or the run-time, or whether a drug should be given intramuscular, oral or as an infusion) can be specied with separate forms. 
ProtocolEditor
The ProtocolEditor enables the physician to dene sequences of chemotherapy and radiotherapy phases which have been specied with the TherapyEditor described above. This covers the specication of constraints concerning the intervals between the successive phases, and the denition of stratication points specifying that { depending on the patient's individual data { one of several therapy branches should beselected. The gures 4 and 5 illustrate the interactive process of specifying the temporal structure of a typical protocol.
The palette at the top of gure 4 provides symbols representing the dierent types of chemo-and radiotherapy which have been dened with the TherapyEditor. This symbols can be dragged to the worksheet beneath to specify the structure of the protocol. Here the physician has specied that, rst of all, a surgical phase is applied (symbol OP). A stratication point (symbol`_' for`OR' ) indicates, that after this surgical unit, the patient is assigned to exactly one of several therapy branches, depending on his individual laboratory values and tumor ndings. The question marks indicate that the rule knowl- edge specifying the stratication criteria has not yet been dened (this can be done with the RuleEditor in one of the next steps). Temporal relationships between protocol components are acquired by dragging an edge between two symbols. The user then is prompted to ll a form containing the quantitative information. In gure 4 the physician is specifying that the chemotherapy of type N2 (upper branch) should start not earlier than 4 weeks after the beginning of the preceding N1-therapy, but not later than 5 weeks. The symbol^' (for`AND') in the bottom branch means that the patient should undergo the N1/N2-sequence and a parallel radiotherapy of the metastases (RT-M). Fig. 5 illustrates the denition of a cyclic protocol structure. In this gure, it is dened that the sequence D1/D2 should begiven 6 times, and that the therapy then should terminate. Rule-based termination criteria, such as`IF Complete remission of tumor THEN terminate cycle', can be dened with the rule editor described in section 2.3. Furthermore, the physician can inspect the components of a chemotherapy by selecting the associated symbol and calling an inspector. In Fig. 5 , the inspector is informing the user that the D2 therapy lasts 7 days and consists of the drugs VCR (=Vincristine) and CP (=Cyclophosphamide). 
RuleEditor
The RuleEditor is used to dene rule knowledge. It covers the denition of local modication or discontinuation criteria valid in the context of a particular chemotherapy, and the specication of initial stratication points and termination criteria in therapy cycles. The RuleEditor can becalled both from the TherapyEditor and the ProtocolEditor, and exports the specied rule to the calling module, which then stores the rule in the appropriate part of the internal semantic network (see section 3 for more details). Figure 6 shows the specication of a rule valid in the context of the chemotherapy N1.
In this gure, the rule is dened that whenever the creatinine-clearance value is less than 70 ml/min during a chemotherapy N1, the drug Cisplatin should be discontinued (as nephrotoxicity { indicated by abnormal creatinine-clearance values { is one of the serious side eects of Cisplatin). This rule is specied by a) selecting the appropriate concepts (such as drug names, or laboratory parameters) in a concept browser at the bottom of the window, and b) by dragging the selected concepts to a worksheet above where they are used to assemble the rule. The rule then is subjected to a syntactic check and transformed to the internal rule notation. The calling editor, which in this case has been the TherapyEditor, imports the rule, and stores it in the subnet representing the N1-chemotherapy.
Protocol Representation
For protocol representation, a semantic network approach has been chosen. In TheMPO, this approach is based on labeled, directed, and attributed graphs 2 . A protocol component such as a cytostatic infusion, a chemotherapy, or a surgical unit is represented through a labeled node (e.g., with the label Infusion); information such as the names of the cytostatic and supportive ingredients, or the daily dosage of a cytostatic component, is stored in attributes associated with the particular label. From the object-oriented point of view, the node labels and their associated attributes form a class hierarchy, the instances of the particular classes being the nodes of the semantic network. Relationships between protocol components, such as temporal or component-of relations, are expressed via labeled and directed edges connecting the nodes in the network. Figure 7 shows the inheritance hierarchy of the attributed node labels, and the gures 8 and 9 illustrate the internal representation of a neuroblastoma protocol.
One basic problem arising in connection with complex network-oriented data structures is the formal description of the class of legal networks. A nextedge may point from a TherapyPhase-node to another, but it is inadequate to connect a Section-node with a RuleSet-node. To formally dene the class of legal protocol networks, a graph-grammar approach has been used. Graphgrammars are a calculus to formally describe the legal manipulations on graphs by dening a nite set of so-called graph productions. This technique, which has its roots in the graph-theory and software-engineering community [5{7], has already been used to specify the semantics of programming languages [8] , to build tools for computer-aided software engineering [7] , and, in the domain of medicine, for the modeling of medical dilemmas and decisions [9, 10] . In the following the theoretical background of the graph-grammar approach is briey described; a detailed description of this calculus can be found in [11, 12] . The global temporal structure is represented by a subnet starting at node 4. The rst therapy phase is a surgical intervention (indicated by the isOfType-edge leading to the surgical subnet which contains the surgical components; this subnet has been omitted here to save space). After that the patient is assigned to one of several therapy branches depending on his individual data. The stratication criteria are stored in RuleSet-nodes; one node for each branch. Fig. 9 . Part of the semantic network representing the structure of the chemotherapy N1 of the neuroblastoma protocol. The TimeTable-node represents the time-matrix specied in gure 3 in section 2, and the RuleSet-node stores rules { such as the Cisplatin-rule in gure 6 { dealing with the modication of a therapy when side eects and toxicity events are detected. An Infusion-node stores all information about a particular infusion, such as the daily dosage and the age dependencies, the solvent conguration and the run-time.
Graph-Grammars
The basic construct of a graph-grammar is the so-called graph production, describing a valid unit of graph manipulation. A production P again is a graph providing substructures for the deletion, generation, and embedding of nodes and edges. Figure 10 shows a simple graph operation of the protocol grammar.
This production would be interpreted as follows:
{ The parts D e l (for the Deletion of nodes and edges) and D e t (for Determined Embedding) specify where the production should take place in the current host graph (i.e. the protocol graph). In this example, the existence of a VisibleNode-node (or a node with a sublabel of VisibleNode { such as TherapyPhase), and an incoming marks-edge with a Cursor-node as its source node, has to be determined. The Cursor-node is used to achieve the unambiguity of a matching region in a host graph, and is usually set by the preceding graph production to indicate where the next production should take place. For instance, a Cursor-node may point to the node representing the chemotherapy currently being edited by the TherapyEditor.
Furthermore, to avoid the problem of several matching regions in the host graph, productions can beprovided with additional constrains for the starting region. In so-called preambles it is possible to specify that some node attributes of the matching region must fulll specied conditions, or P will not be processed. { If the structure specied by D e l and D e t does not exist, the production is aborted. Otherwise, the following steps have to be done:
Delete the structure specied in Del. In the case of Figure 10 , remove the Cursor-node and the outgoing marks-edge. Process the Gen-part of the production (for Generation of nodes and edges). In this case, create a TherapyPhase-node and an EntryTime-node, and connect them with a hasEntryTime-edge (in the specied direction).
After that, embedthe new nodes into the existing host graph. This embedding is processed in two steps. The rst step is described by the substructure called Det (for Determined Embedding), and denotes an embedding which is carried out anyway (therefore determined), as the substructure Det does exist in the graph (otherwise, the production would not have been launched). In this example, the determined embedding consists of simply connecting the TherapyPhase-node with the VisibleNode-node through a next-edge, and of linking the EntryTime-node to the VisibleNode-node via a nextEntryTime-edge.
The second part (Ind for Indeterminate Embedding) describes an embedding which depends on the current structure of the surrounding host graph, and therefore is not known in advance. In this simple example, the Indeterminate Embedding is empty. Figure 13 in section 5 provides a more complex production with indeterminate embedding 6 = ;.
{ The last step of this production processes the attribution commands in the Body-Statement (e.g., the assignment of the value of the parameter begin to the entryTime-attribute of node 3 (the new EntryTime-node).
More generally and formally, and given a set of edge labels E and attributed node labels N , a graph-grammar is a triple (S; P; T ), where { S is a start graph, { P a nite set of graph productions, and { T a nite set of graph transactions.
A start graph S is a graph built from elements of N and E , the attributes of all nodes of S having dened values. The start graph is generated when a new protocol is dened with the ProtocolEditor, and provides a tree to organize and group the protocol components and time-tables. Graph productions dene the valid basic manipulations on a graph and have the structure shown in gure 10. Furthermore, graph productions can begrouped together to graph transactions. A graph transaction is an indivisible sequence of graph productions which has to be carried out entirely or { if an error occurs during the processing of the production rules { has to reset the graph to the state before the transaction was launched. By using transactions inconsistent states of the protocol graph can be avoided.
Formally, a protocol graph is valid if it can bederived from the start graph S by using transactions only of the protocol graph-grammar. In practice, the validness of the protocol network and especially the referential integrity is enforced by allowing external modules only to call public transactions of the grammar. The graph-grammar approach i n troduced and illustrated above has been used to model and develop the oncological knowledge base of TheMPO. All together, the recent protocol graph-grammar consists of 36 generic graph productions and 30 graph transactions which can be parameterized with node and edge labels and attribute-values.
In conclusion, it can be stated that graph-grammars are an appropriate calculus to formally describe complex graph manipulations which have to beprocessed during protocol acquisition. Entity-Relationship models, for instance, which also specify the valid structure of graphs, don't provide a formalism to describe the dynamics of network transformation processes. The graphgrammar approach introduced has been used to describe the structure and the dynamical behavior of the protocol graph formally on a high level of abstraction without having to take care of implementation details. With this approach conceptual errors can be avoided or detected at an early stage. The graph-grammar model for instance only claims that edges between nodes are represented explicitly; it does not make a n y assumptions concerning the ques-tion how these edges are realized in detail (e.g., through adjacency-matrices or adjacency-lists). This is an implementation issue (see section 6) as well as the realization of graph transactions with the low-level transaction mechanism of a database.
Rule Representation
Rules which have been specied with the RuleEditor described in section 2 are internally stored in Clips, which is a rule-based language with forwardchaining inference [13] . For each ChemoTherapy-node in the protocol network, there exists a RuleSet-node which is connected with the ChemoTherapy-node via a hasComponent-edge, and which stores rules valid only in the context of this particular chemotherapy (see gure 9 as well). If a patient passes through the chemotherapy represented by this ChemoTherapy-node, the relevant rules can easily be retrieved by accessing this associated RuleSet-node.
Medical Problem Solving
To model the oncological problem solving process, a modication of the method Episodic-Skeletal-Plan-Renement, based on the works of [14] , has been used. This problem-solving method consists of the three subtasks Propose-and-Calculate-Plan, Identify-Problem and Revise-Plan. These subtasks will now bedescribed briey.
Proposing and Calculating a Plan
When a pediatric patient is admitted to hospital after a cancer disease has been diagnosed or a therapy-free interval has nished, the propose-plan module reasons about the appropriate therapy to administer next. This is done by exploring the semantic network described in section 3. If, for example, the patient has recently nished a chemotherapy o f t ype N1 and is then recovering in a therapy-free interval, the problem-solver explores outgoing next-edges to identify the next therapy phase, processes the temporal constraints in EntryTime-nodes to suggest the time for starting the next phase, and loads and processes rules stored in RuleSet-nodes to determine whether the patient fullls all criteria for starting the therapy phase. This problem solving process can explicitly be launched by the physician for a given patient, or can be done through a demon process scanning the patient database (preferably at night) to determine which patients have to be prepared for which type of therapy. Fig. 11 . Suggestions of the medical problem solver for two (ctitious) patients. Figure 11 shows the suggestions of the problem solver for two patients in the database.
For the rst patient in this gure, who is currently recovering from the 1st chemotherapy of type N2, the problem solver for example has suggested to start the next chemotherapy (type N1) on 13 Sep 1995. The physician can agree, disagree, or postpone the decision. If the button entitled with Explanations ... is clicked, the problem solver a) invokes the ProtocolEditor to load and view the relevant part of the protocol, and b) loads the individual patient data which have led to the suggestion. In the box underneath, the physician can inspect the diagnostic procedures which h a v e to be done before the patient e n ters the chemotherapy, and can add or remove procedures. If the physician agrees to the suggestion of the problem solver (e.g., agrees that the next chemotherapy should be of type N1 and should start at the suggested date), a submodule is launched to calculate the patient-adapted daily dosages of the drugs of the chemotherapy. The knowledge about the components of a chemotherapy, its time-table and the daily dosages is retrieved from the subnet shown in gure 9. Furthermore, portioning and event plans can be calculated for the nursing sta, giving the information at which time the infusions have to be administered, and which infusion rates have to be tuned in.
To achieve transparency of the underlying medical reasoning, the problemsolving process has been explicitly described with a CML-oriented language. CML (= Conceptual Modeling Language) [15] is a semi-formal specication language to describe the expertise model of knowledge-based systems, and has been developed within the CommonKADS-research project (e.g., [16] ). CML provides constructs for the specication of ontologies, basic inference steps, and complex tasks. The following example shows the specication of the task T ProcessRuleBasedAssignment, which is a subtask of the proposeplan-module, and which determines an appropriate risk group for a particular patient (the prex T denotes a task, the prex I an inference): This tasks tries to derive an appropriate assignment for the patient identied by patient-id and currently undergoing the protocol protocol-id. Therefore, the assignment rules stored in the protocol subnet identied by assign-id are processed, and relevant information about missing or uncertain data, or data which do not exactly match the temporal requirements of the rules, is stored in the list record-access-results. The task T ProcessRule is the central subtask invoked from T ProcessRuleBasedAssignment. This subtask does not only process the assignment rule itself by communicating with the internal Clips-interpreter, but collects and maintains all relevant information concerning the patient data accessed during rule processing. When T ProcessRule has nished, this information is represented in the output-list tmp-record-access-results, which provides a structured entry for every patient parameter accessed during rule processing. To illustrate this, the following typical assignment rule is used as an example: IF risk factor 3 0:8 at day 1 (of initial chemotherapy) AND peripheral leukemia cells < 1000 at day 8 AND blast cells in bone marrow < 5 p ercent at day 33 AND ... THEN assign patient to risk group MRG Depending on the data situation in the patient record, the list tmp-recordaccess-results would provide information about the following rule processing events': (i) Unavailable data:
For example, tmp-record-access-results may store that there is NO information at all about the number of peripheral leukemia cells in the record, and that therefore the rule could not have been applied. Information about missing data may be irrelevant as other assignment rules may have been able to re, but this information becomes important for the physician, if NONE of the rules has been able to conclude a risk group for the patient. In the latter case, the task invoking T ProcessRuleBased-Assignment would process the output list record-access-results (which is a collection of the tmp-record-access-results-lists), and would, for example, detect that the assignment has failed because of a missing leukemia cells value required by each of the rules. Therefore, an alert would be generated informing the physician that this parameter should beinspected as soon as possible.
(ii) Temporal mismatch:
Because of the organizational and medical complexity of the diagnostic and therapeutic procedures, and because of the patient's medical individuality, a patient parameter { although available in the record { may not exactly match the temporal constraints of the rule, e.g., the blast cells of the bone marrow may have been inspected on day 31 instead of day 33. Therefore, to avoid decisions based on data being to old in the current clinical context, the temporal match is measured in the following way during rule processing: { Let F i denote the nding parameter i appearing in the premise of a rule R with n ndings (e.g., F i =`blast cells in bone marrow (in percent)'). { Let t F i denote the time point for which F i is requested (e.g., t F i = d a y 33). The granularity of time depends on the particular parameter and the specic context of the rule; in the domain of pediatric oncology, days can be viewed as the central time units. However, in particular situations such as the application of the drug Methotrexate and the corresponding folin acid rescue, time has to be modeled on the level of hours. { Let P i denote the corresponding patient parameter (and its value) in the record, and let t P i denote the time point of inspection of P i (e.g., P i =`blast cells in bone marrow = 4 percent' have been examined on t P i =`day 32'). If there are \competitors" P i 1 ; P i 2 with j t F i t P i 1 j=j t F i t P i 2 j, then the systems usually selects the most recent v alue P i j (j 2 1; 2) available in the patient database 4 . { Let tol F i ;t F i ;C denote the temporal tolerance limit of F i at t F i in the current protocol context C . F or example, if t F i =`day 33' and tol F i ;t F i ;C = 2 (days), then t P i = 30 would beinterpreted in the way that the parameter P i is too old to be considered valid for rule R. The value of tol F i ;t F i ;C strongly depends on the particular context C ; if, for exam-ple, F i is a hematological parameter, tol F i ;t F i ;C usually is signicantly smaller during a chemotherapy than during a recovering phase, because of the massive hematological side eects of the chemotherapy. The particular value of tol F i ;t F i ;C is retrieved from the knowledge base during rule processing. { Then, the degree of temporal matching between F i and P i in a context C is measured through:
T M ( F i ; P i ; C ) = 8 > < > : 0 , i f j t F i t P i j > tol F i ;t F i ;C ; tol F i ;t F i ;C tol F i ;t F i ;C +jt F i t P i j else
This term is 1, if t F i = t P i , and decreases if the dierence d i =j t F i t P i j between t F i and t P i increases. If a parameter has a relatively small temporal tolerance limit, d i is weighted stronger than if there is a larger tolerance limit. { If F i 1 ; : : : ; F i j is the subset of nding parameters F 1 ; : : : ; F n of rule R for which the corresponding P i 1 ; : : : ; P i j w ould fulll the premise of R, then the temporal match of P i 1 ; : : : ; P i j is measured through: If T ProcessRule processes a rule R with nding parameters F 1 ; : : : ; F n , it rst inspects whether there is a patient data combination P i 1 ; : : : ; P i j fullling the premise of R, and checks whether the match T C M R;P i 1 ;:::;P i j is larger than a given threshold t. I f y es, the match is considered to be sucient, and the rule res, and the patient is assigned to the risk group in the conclusion of R. If not, T ProcessRule selects another combination P j 1 ; : : : ; P j m fullling the premise of R from the record, and again calculates T C M . This is done until a patient parameter combination is found which fullls the premise of R, and where the match T C M is larger than the threshold, or until no subset P j 1 ; : : : ; P j m fullling the premise of R is left. This algorithm is fairly simple, if the F 1 ; : : : ; F n are connected via AND-operators (as then there is { at best { only one combination fullling the premise, i.e. P 1 ; : : : ; P n ), but it becomes more complex when there are OR-conjunctions in R. During rule processing, T ProcessRule maps all information about temporal/certainty mismatches (and unavailable data) to the output list tmp-record-access-results for further inspection.
Identify-Problem and Revise-Plan
As only a small numberof patients passes long-term treatment without signicant side-eects, the internal problem-solver also has to identify problems caused by the aggressive therapy, and has to decide whether to reduce or discontinue a drug or drug combination, or whether to administer additional procedures for toxicity management. Therefore, when a chemotherapy i s g i v en to a patient, all rules stored in the RuleSet-node associated with this chemotherapy are loaded by the internal Clips-interpreter. As dierent types of chemotherapy are characterized by very dierent types of side-eects and toxicity, and therefore require very specic therapy modication, this RuleSet-node represents rules which are valid only in the context of this particular chemotherapy, and which have been specied with the graphical RuleEditor of section 2.3. If patient data are entered into the record, the Clips-forward chainer then processes the rules to detect abnormal and dangerous situations (e.g., Creatinine-Clearance (ml/min) < 70 ), and suggests therapy modications such as Discontinue Cisplatin.
Patient Record
To store a patient's diagnostic data and course of treatment, TheMPO provides an electronic patient record as a source for retrospective inspection and medical decision making. The main component of the underlying patient model, which is based on semantic networks too, is a temporal subnet for the representation of the course of treatment. This temporal net represents medical events such as the administration of a cytostatic drug through labeled, attributed nodes, while temporal relationships are modeled with labeled edges. Figure 12 for example shows the internal representation of a chemotherapy administered to a particular patient.
The graph in this gure represents the administration of the chemotherapỳ I' within the leukemia protocol`ALL-BFM-95' (node labels are given inside the boxes, attribute-values are placed beside the boxframes). Days of treatment and phases of chemotherapy are modeled explicitly, and not implicitly through a set of time-stamped data. Medical events such as the administra- tion of a cytostatic drug like Prednisone are related to PatDay-nodes via hasEvent-edges. Furthermore, the subgraph shown in this gure represents the causal context that Asparaginase has been discontinued on 15 March 1995 because of a serious hyperglycemia trend { described by the node labeled with PatTrend { which has developed since 14 March 1995. To control the hyperglycemia, Insulin has been administered. The explicit representation of becauseOf -or discontinuedBecauseOf -relationships enables the record to directly answer questions such as Why has the obligate drug Asparaginase been discontinued on 15 March 1995? Similar to section 3, a graph-grammar approach has been used to manage the complex graph transformations driven by information entry and medical problem solving. Figure 13 shows a typical graph production of the patient graph-grammar.
This production maps an inconsistency (detected by the physician or the problem solver) between two (diagnostic) data items { such as a new laboratory value being not consistent to the current diagnosis { to the patient graph. The production in this gure is parameterized with: (1) the labels of the conicting nodes (rstPart and secondPart), (2) a string for additional comments (description), and (3) the (day) time of detecting the inconsistency (time).
After having found the matching region in the patient graph, the production generates an Inconsistency-node (node 5) and connects it with the two conicting nodes (1 and 2) via inconsistencyPart-edges and the global CheckList-node (determined embedding). After that, the indeterminate embedding is processed: First of all, it is explored whether node 1 or node 2 is connected with MedEvent-nodes through becauseOf -edges. If this is not the case, the production terminates successfully. Otherwise, the production connects every detected MedEvent-node with the new Inconsistency-node via a weakens-edge (if node 6 and 7 in the Ind-eld are identical, the weakens-edge is drawn only once). The rationale behind this behaviour of the production is the following: Whenever a MedEvent-node n (which may, for example, represent a medical conclusion or a therapeutic procedure) is based on one of the nodes 1 or 2, which are now integrated into an Inconsistency-context, then n should be marked as a node whose medical validity i s w eakened by the detected inconsistency. Whenever the physician loads a window containing the information represented by n, then the system will generate a message that there exists a related data context which has been viewed as an inconsistency, and which therefore (possibly) weakens the validity o f n .
F or the acquisition of semantic relationships such as the discontinuedBecauseOfedge between the Asparaginase-node and the hyperglycemia-node in gure 12, or the inconsistency context in gure 13, the TheMPO-record provides graphical mouse-based tools which enable the physician to specify relationships between medical events interactively. Figure 14 shows the acquisition of a causal context during a chemotherapy N1 of the neuroblastoma protocol.
In this gure the physician species that he has reduced the Cisplatininfusion on 5 May 1995 because of a decreased creatinine-clearance detected o n 4 M a y 1995. This specication is done by dragging with the mouse from the Cisplatin-window to the eld representing the data responsible for the re- duction of the drug dosages (e.g., creatinine-clearance of 70 ml / min). During the drag process a black arrow appears on the screen indicating the connection between the two events. The program, which has registered that the dosages have been reduced (by comparing the two dosage columns), assumes that the physician wants to specify a reducedBecauseOf -context because he has connected a drug-window with a window showing laboratory data. If the physician conrms this assumption, the program generates a reducedBecauseOf -edge in the patient graph between the Cisplatin-node and the creatinine-node.
Principally, the patient graph does not only allow the representation of contexts such as causal relationships and inconsistency clusters, but also reects the main classes of queries occurring in the daily routine (i.e. interval-oriented queries and parameter-oriented queries). This is done by linking every MedEvent-node a) to the PatDay-node representing the day of the event (as shown in gure 12) and b) by linking all nodes of a given MedEvent-subclass together via next-edges to represent the temporal course of a parameter (see gure 15).
Therefore, by using the query-oriented graph structure, querying of the patient graph is -in most of the cases -done in two steps: The query rst takes advantage of the graph organization to reduce the search space, and then uses OQL (= Object Query Language 5 )-commands of the database sys- It is updated dynamically according to the specic procedures applied to the patient, and serves as an entry point for queries to reduce search space (e.g. by jumping directly to the FlowsheetRow-node for the hemogram reports when the hemogram values are requested for a longer time-period). Furthermore, the user interface menu of the patient's record is dynamically generated from this TOC.
tem to lter the node-lists in the reduced search space. If, for example, the physician wants to inspect all cytostatic drugs for a given time interval such as a particular chemotherapy, the query algorithm rst jumps to the node representing this chemotherapy (by following the next-edges connecting the PatChemotherapy-nodes), and then explores the subtree consisting of the hasDay-and hasEvent-edges (by ltering the list of all MedEvent-nodes within this chemotherapy with OQL). On the other hand, if for instance all time intervals have to befound where the hemograms of the patient fulll a specic condition (such as leucocytes > 20000), the query jumps to the rst PatHemogram-node in the patient record by using a subgraph representing the patient-specic table of contents (see gure 15), and then uses OQL to lter the PatHemogram-nodes and to determine the requested intervals. This Data Management Group and implemented in most of the available objectoriented database systems. It provides query capabilities similar to those of Sql, with additional object-oriented features such a s i n v oking object methods and ltering their return values, and path expressions to navigate through object networks.
approach of additional query-oriented graph structuring has been considered necessary, as the record of a patient usually covers long time periods (from 6 months up to two years), which implies hundreds of instantiations of a particular parameter on the time axis.
A detailed description of the context-oriented TheMPO-record can be found in [17] .
Implementation Issues
To implement the protocol and patient model, the object-oriented C++-database Poet in the NeXTSTEP-environment has been used. To represent nodes and edges, the abstract data types Graph and GraphNode have been implemented in C++/Poet. These data types encapsulate elementary graph-functionality (e.g., adding and removing nodes and edges). For internal graph representation adjacency-lists were used instead of adjacency-matrices because the question in which contexts a node is embedded arises often. With adjacency-lists { separated by incoming and outgoing edges { each n o d e i s i nformed about his`next-door'-neighborhood and can quickly answer questions such as`Are there any outgoing next-edges leaving you?' 6 . Graph productions and graph transactions have been implemented as C++-functions using the low-level transaction-mechanism of Poet.
To realize the graphical acquisition tools described in section 2 the AppKitObjective-C libraries of NeXTSTEP [19] were used allowing comfortable programming of complex graphical user interfaces. Rules, which have been dened with the RuleEditor, are parsed and translated to Clips with a compiler generated by Yacc and Ox [20, 21] .
Related Work
The knowledge-based system TheMPO clearly stands in the Oncocin/Opal tradition. Oncocin [14] is an expert system supporting therapy planning and monitoring in adult oncology, and provides a graphical acquisition tool (Opal [22] ) for protocol authoring similar to the tools described in section 2. However, Opal and TheMPO for example dier in the acquisition of rule knowledge. Opal provides several structured forms for important classes of rule knowledge which have been considered to beimportant in the domain; with these forms, the user can easily specify rules of a predened structure. In the domain of pediatric oncology, however, the structure of rule knowledge used for stratication and therapy modication is too heterogeneous to be covered by an acceptable number of acquisition forms. Therefore, a rule editor has been implemented allowing the specication of rule knowledge not restricted to a small numberof rule classes. Concerning the patient records of the two systems, the temporal network Tnet/Etnet [23] of the Oncocin-record is comparable to the temporal graph of the TheMPO-patient record shown in gure 12. However, the Oncocin-record is not able to explicitly represent causal relationships between patient data, as it is for example shown in gure 12, where the causal context is represented, that Asparaginase has been discontinued because of a detected hyperglycemia-trend. In the domain of protocol-directed pediatric oncology, where signicant therapy modications may result in removing the patient from the clinical trial associated with the protocol, the explicit representation of the medical decision process has been considered necessary.
Catipo (Computer Aided Therapy in Pediatric Oncology) [4] is a system for automated chemotherapy calculation in the domain of childhood cancer. It has a knowledge base for the dierent types of chemotherapy, and an alpha-numerical editor for chemotherapy denition. However, it does not provide modules supporting other types of therapy (e.g. radiation), has no representation of the protocol structure (such as the one in gure 1), and does not include a persistent patient record. Its encouraging results in clinical routine chemotherapy calculation { it is currently used in about 15 childhoodcancer centers in Germany { have been one of the motivations for the TheMPO-project. Sepia [24] is an expert system for monitoring patients hospitalized in hematooncology departments to undergo clinical protocols. Sepia, which is based on the control-theory paradigm, provides powerful mechanism for detecting critical laboratory value trends, for modifying therapy and diagnostic procedures as a consequence, and for meeting real-time constraints. From a more abstract, domain-independent point of view, TheMPO and Sepia can be viewed as complementary systems: TheMPO focuses on elaborate therapy planning and conguration based on complex standardized protocols, Sepia on the detection and management of critical situations during protocol-application.
OncoCons (= Oncology Consultant) [25] is a knowledge based system covering a broad range of functions in the domain of adult oncology. This includes an oncological record with watch-dog functionality (OncoDoc), a module for long-term monitoring (OncoMon), a subsystem for radiotherapy (OncoCart), and a multimedia-based training and information system (OncoHelp). Beside the fact, that OncoCons is adapted to the domain of adult cancer diseases, which signicantly diers from pediatric oncology, TheMPO focuses on knowledge acquisition and processing aspects, while the Oncotools concentrate on an elaborate knowledge-based documentation and training functionality.
Conclusion and Open Problems
This article focused on the acquisition, representation, and processing of oncological protocols in the domain of childhood cancer. The knowledge-based system TheMPO, developed to support physicians in this complex domain, provides graphical tools for the acquisition of protocol knowledge, a problemsolver reasoning about adequate therapy steps for a given patient, and a patient record. TheMPO incorporates several methodologies, as the domain knowledge in the eld of pediatric oncology is too heterogeneous to be covered by a single approach. Planning knowledge, for example, is represented through a semantic network; the complex network transformation processes driven by knowledge acquisition, problem solving and data entry, are formally described and controlled by a graph-grammar. Moreover, the network and graph-grammar representation is realized in an object-oriented manner. For example, the nodes in the network are instances of classes within an inheritance hierarchy, providing public methods for external modules to explore or modify their attributes or local neighborhood (e.g., a graph-grammar production inserting a new node and edge into the semantic network simply invokes an AddNode(aNodeId)-and an InsertEdge(aSourceNodeId, aTargetNodeId, anEdgeId)-method of the interface of the Graph-instance representing the network, which then handles the internal updating of the global node list and the aected adjacency-lists). On the other side, rule representation and data-driven rule processing, which is of importance for the subdomain of toxicity management, can be expressed and processed in a more natural and ecient way by a rule-based language and interpreter. In this case, the forward-chaining Clips-environment has been chosen, as Clips is easy to integrate into a C++-based application. Therefore, rules valid in the context of a particular chemotherapy are stored in the RuleSet-node of this chemotherapy, and are loaded by the Clips-interpreter (the interpreter itself is invoked by the global problem-solver as a subprocess), when a patient is treated with this chemotherapy.
However, there are several problems and shortcomings which have to beaddressed in the future. First of all, the critical tool in the suite of acquisition tools is the RuleEditor, as it has not been proved yet whether this com-plex experimental tool can really be used by physicians. The complexity is caused not mainly by building up the rule itself than by dealing with the error messages of the rule parser. Future eorts have to concentrate on informative and suggestive error messages of the parser understandable not only for computer scientists. Furthermore, as a powerful semantic check of rules detecting for instance subsuming or conicting rules has not yet been developed, work has to bedone addressing this important topic. Another shortcoming of the system is the inability to deal with complex trend knowledge which is of particular importance for an eective monitoring. Currently, TheMPO does not provide a mechanism to acquire, represent and process trend knowledge more complex than for instance the obviously simple hyperglycemia trend of gure 12. Future work, based on the works of Shahar [26] and Kahn [27] , has to concentrate on this topic.
Furthermore, as large hospitals are characterized by extremely heterogeneous electronic information processing environments, additional work has to be done to integrate the system into existing, Windows/SQL-dominated clinical networks and information systems.
A rst phase of clinical testing and evaluation of the system has started in the begin of 1997 at the Children Hospital of the University of Mainz. The rst step of evaluation has focused on the testing of the modules calculating a chemotherapy such as the one shown in gure 14, where the system has suggested the dosages of one of the involved drugs. This testing has been done by the following substeps: { First of all, the systems had to recalculate a signicant numberof former chemotherapy treatments, which have already been applied to former patients, and which have been considered to be correct. The results of the recalculation then have been compared with the dosages that have been given. The basic intention of this step was to detect a n umberof relatively trivial system bugs, which have not been detected in the computer laboratory when using only a few generated test data of ctitious patients, and to demand the time of physicians only minimally, as this step was done mainly by the developers of the system. Furthermore, during this step, the relatively simple, though time-consuming acquisition of the chemotherapy knowledge was mainly done by the developers too (with the TherapyEditor). The latter is possible, as protocols specify chemotherapy treatments precisely. { The next step then consisted of calculating chemotherapy treatments of patients (currently being hospitalized at that time) simultaneously by the program and by an experienced physician, and by comparing the results. Again, chemotherapy acquisition has been done by the developers, to reduce the amount o f w ork for the physicians during this step. Currently, the results of these two steps are analyzed.
{ If the modules calculating the chemotherapy have been considered to work correct and to provide an ergonomic user interface, the next step consists of calculating the drug dosages of current patients by the system solely (including a nal plausibility inspection of the dosages by the physician).
As the manual calculation of complex chemotherapy units is one of the most time-consuming activities for physicians, a success concerning this step has to be viewed as being critical for the acceptance and motivation of physicians in using the complex system. { If the physicians accept the chemotherapy calculation modules, testing shifts to acquisition aspects. First of all, the acquisition of the chemotherapy knowledge (with the TherapyEditor) through physicians is tested, and it is analyzed how to optimize this process concerning user interaction and ergonomic issues.
If the chemotherapy modules (including the TherapyEditor) as the core of the system have been proved to be correct and have been accepted by the medical sta, evaluation is extended to the more complex tools such as the ProtocolEditor, the RuleEditor, and the problem solvers processing risk group assignments and suggesting new therapy units after recovering phases.
Summary
This article introduced the knowledge-based system TheMPO (Therapy Management in Pediatric Oncology), which supports protocol-directed therapy planning and conguration in pediatric oncology. TheMPO provides several graphical acquisition tools for knowledge base authoring, which hide the internal representation language and enable the physician to edit protocols and units of therapy in a diagram-oriented way known from the paperbased protocols. The internal protocol representation approach is mainly based on semantic networks, but also uses a rule-based approach for specic subsets of protocol knowledge (e.g., toxicity detection and management). Graphgrammars have been used to formally describe the class of legal protocol graphs. A problem-solver, specied with the CML-modeling language, and implemented in C++/Clips suggests patient-adapted therapy plans and detects critical toxicity situations. The network/graph-grammar approach of the protocol knowledge base has been used for the corresponding patient record too, as the course of treatment of a particular patient can be viewed as a graph build around a path through the protocol network. Beside storing the diagnostic and therapeutic procedures, the patient record of TheMPO focuses on the explicit representation of semantic relationships between medical data, e.g. the record may represent the causal context that a Cisplatin-infusion has been reduced because of a pathological creatinine-clearance value. The acquisition of contexts is also done by graphical tools. The next main steps have to concentrate on the analysis of the rst clinical evaluation phase which has started at the begin of 1997, and an integration of the system into a Windows/SQL-dominated hospital environment. 
